ドラッグデリバリーシステム市場：デリバリータイプ、製剤、薬物放出メカニズム、用途、エンドユーザー別-2025-2030年世界予測

ドラッグデリバリーシステム市場は、2023年に370億4,000万米ドルと評価され、2024年には390億2,000万米ドルに達すると予測され、CAGR 5.70％で成長し、2030年には546億1,000万米ドルに達すると予測されています。

ドラッグデリバリーシステムの対象範囲には、治療薬の標的送達と制御放出に使用される技術が含まれます。これらのシステムは、薬剤が最適な濃度で目的の作用部位に到達することを保証することにより、医薬治療の有効性、安全性、患者のコンプライアンスを高めるために不可欠です。ドラッグデリバリーシステムは、経口剤、注射剤、経皮剤、吸入剤、埋め込み型デバイスなど様々な様式に適用され、病院、診療所、在宅介護の幅広い最終用途に対応しています。洗練されたドラッグデリバリー機構の必要性は、バイオテクノロジーやナノテクノロジーの進歩に後押しされ、より正確で効率的、かつ患者に優しい治療ソリューションへの継続的な需要によって強調されています。

この市場に影響を与える主な成長要因には、慢性疾患の有病率の増加、生物製剤とバイオシミラーの需要拡大、送達技術の技術革新などがあります。さらに、個別化医療と生物学的療法の増加は、標的作用とバイオアベイラビリティを向上させる新規デリバリーシステムに大きな機会をもたらしています。例えば、スマートドラッグデリバリープラットフォームやマイクロパーティクル技術などの技術革新は、高い成長が見込まれる潜在的な分野です。こうした機会を生かそうとする企業は、生分解性ポリマーやナノキャリアなどの最先端システムの研究開発に投資すべきです。しかし、市場は規制の複雑さ、開発コストの高さ、バイオテクノロジーの知識の限界といった課題に直面しており、これが技術革新と採用の速度を阻害しています。

薬物の安定性と患者のアドヒアランスの限界も、対処が必要なハードルとなっています。今後の技術革新は、材料科学と工学の開発を強化し、より適応性と応答性の高い送達システムを作り出すことによって、これらの障壁を克服することに焦点を当てるべきです。デジタルヘルス技術の相乗的な利用を探求することで、モニタリングと管理をさらに洗練させ、ドラッグデリバリーの状況を向上させることができます。全体として、ドラッグデリバリーシステム市場はダイナミックかつ課題的な市場であり、新たな機会を捉え、持続的な市場成長を促進するためには、技術と規制のナビゲーションへの戦略的投資が必要です。

市場力学：急速に進化するドラッグデリバリーシステム市場の主要市場インサイトを公開

ドラッグデリバリーシステム市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響についてより明確に理解することができます。

• 市場促進要因
  • 世界の慢性疾患・感染症の流行拡大
  • ヘルスケア・インフラへの政府支援の高まり
  • 個別化医療に対する需要の高まり
• 市場抑制要因
  • ドラッグデリバリーシステムの開発に伴う高コスト
• 市場機会
  • ドラッグデリバリーシステム製造における技術の進歩
  • 効率的な標的ドラッグデリバリーシステムのためのナノテクノロジーの採用拡大
• 市場の課題
  • 規制上のハードルと時間のかかる承認プロセス

ポーターの5つの力：ドラッグデリバリーシステム市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、ドラッグデリバリーシステム市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ドラッグデリバリーシステム市場における外部からの影響の把握

外部マクロ環境要因は、ドラッグデリバリーシステム市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ドラッグデリバリーシステム市場における競合情勢の把握

ドラッグデリバリーシステム市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスドラッグデリバリーシステム市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ドラッグデリバリーシステム市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ドラッグデリバリーシステム市場における成功への道筋を描く

ドラッグデリバリーシステム市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で慢性疾患と感染症の蔓延が増加
    • ヘルスケアインフラへの投資増加、政府支援
    • 個別化医療の需要の高まり
  • 抑制要因
    • ドラッグデリバリーシステムの開発に伴う高コスト
  • 機会
    • ドラッグデリバリーシステムの生産における技術的進歩
    • 効率的なターゲットに向けたナノテクノロジーの採用拡大ドラッグデリバリーシステム
  • 課題
    • 規制上のハードルと時間のかかる承認プロセス
• 市場セグメンテーション分析
  • 投与方法：長期にわたる制御された薬剤放出を保証するために、経皮ドラッグデリバリーの採用が拡大しています。
  • 応用：糖尿病の世界の蔓延により、持続的なドラッグデリバリーシステムの必要性が高まっています。
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ドラッグデリバリーシステム市場配送タイプ別

• 吸入ドラッグデリバリー
• 注射によるデリバリー
• 鼻腔内ドラッグデリバリー
• 眼科ドラッグデリバリー
• 経口ドラッグデリバリー
• 局所ドラッグデリバリー
• 経皮ドラッグデリバリー

第7章 ドラッグデリバリーシステム市場処方別

• ガス
• 液体
• 半固体
• 固体

第8章 ドラッグデリバリーシステム市場薬物放出メカニズム別

• 制御放出
• 即時リリース
• 持続放出
• ターゲットリリース

第9章 ドラッグデリバリーシステム市場：用途別

• 心血管疾患
• 中枢神経系疾患
• 糖尿病
• 感染症
• 腫瘍学
• 呼吸器疾患

第10章 ドラッグデリバリーシステム市場：エンドユーザー別

• 診断センター
• ホームケア設定
• 病院・クリニック

第11章 南北アメリカのドラッグデリバリーシステム市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域のドラッグデリバリーシステム市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカのドラッグデリバリーシステム市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • Schott PharmaとKoru Medical Systemsが提携し、患者ケアの向上を目指して革新的なドラッグデリバリーを開発
  • ディフゲン、FDA登録施設の買収により生産と品質を向上
  • シャープステクノロジー、患者の安全性を高め、投与リスクを軽減する新しいドラッグデリバリーシステムを発表
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• AptarGroup, Inc.
• AstraZeneca Plc
• Boston Scientific Corporation
• Cospheric LLC
• DelSiTech Ltd.
• Enable Injections, Inc.
• F. Hoffmann-La Roche Ltd.
• Insulet Corporation
• Johnson & Johnson Services, Inc.
• Lonza Group Ltd.
• Merck KGaA
• Merit Medical Systems, Inc.
• Novartis AG
• Pacira BioSciences, Inc.
• Pfizer Inc.
• Polysciences Inc.
• Sanofi S.A.
• SHL Medical
• Societal CDMO by CoreRx, Inc.
• Terumo Corporation
• Thermo Fisher Scientific Inc.
• West Pharmaceutical Services, Inc.

LIST OF FIGURES

• FIGURE 1. DRUG DELIVERY SYSTEMS MARKET RESEARCH PROCESS
• FIGURE 2. DRUG DELIVERY SYSTEMS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. DRUG DELIVERY SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. DRUG DELIVERY SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DRUG DELIVERY SYSTEMS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DRUG DELIVERY SYSTEMS MARKET DYNAMICS
• TABLE 7. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INHALATION DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTION-BASED DELIVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY NASAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY OCULAR DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TOPICAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GAS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SEMISOLID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SOLID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SUSTAINED RELEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TARGETED RELEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 54. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 55. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 81. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 82. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 86. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 87. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 91. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 92. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 96. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 97. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 101. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 102. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 106. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 107. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. SINGAPORE DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. SINGAPORE DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 111. SINGAPORE DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 112. SINGAPORE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. SINGAPORE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. SOUTH KOREA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 115. SOUTH KOREA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 116. SOUTH KOREA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 117. SOUTH KOREA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. SOUTH KOREA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. TAIWAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. TAIWAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 121. TAIWAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 122. TAIWAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. TAIWAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. THAILAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. THAILAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 126. THAILAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 127. THAILAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. THAILAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. VIETNAM DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. VIETNAM DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 131. VIETNAM DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 132. VIETNAM DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. VIETNAM DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 136. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 137. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 140. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 142. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 143. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. EGYPT DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. EGYPT DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 147. EGYPT DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 148. EGYPT DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. EGYPT DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. FINLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 151. FINLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 152. FINLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 153. FINLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. FINLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 156. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 157. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 158. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 160. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 161. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 162. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 163. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 165. ISRAEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 166. ISRAEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 167. ISRAEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 168. ISRAEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. ISRAEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 171. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 172. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 173. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 176. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 177. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 178. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 180. NIGERIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 181. NIGERIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 182. NIGERIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 183. NIGERIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. NIGERIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. NORWAY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 186. NORWAY DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 187. NORWAY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 188. NORWAY DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. NORWAY DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 190. POLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 191. POLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 192. POLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 193. POLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 194. POLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 195. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 196. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 197. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 198. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 199. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 200. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 201. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 202. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 203. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 204. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 205. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 206. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 207. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 208. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 209. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 210. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 211. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 212. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 213. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 214. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 215. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 216. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 217. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 218. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 219. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 220. SWEDEN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 221. SWEDEN DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 222. SWEDEN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 223. SWEDEN DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 224. SWEDEN DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 225. SWITZERLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 226. SWITZERLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 227. SWITZERLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 228. SWITZERLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 229. SWITZERLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 230. TURKEY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 231. TURKEY DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 232. TURKEY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 233. TURKEY DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 234. TURKEY DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 235. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 236. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 237. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 238. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 239. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 240. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
• TABLE 241. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 242. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 243. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 244. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 245. DRUG DELIVERY SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 246. DRUG DELIVERY SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

The Drug Delivery Systems Market was valued at USD 37.04 billion in 2023, expected to reach USD 39.02 billion in 2024, and is projected to grow at a CAGR of 5.70%, to USD 54.61 billion by 2030.

The scope of drug delivery systems encompasses the technologies used for the targeted delivery and controlled release of therapeutic agents. These systems are vital for enhancing the efficacy, safety, and patient compliance of pharmaceutical treatments by ensuring that drugs reach their intended site of action in optimal concentrations. Drug delivery systems are applied across various modalities including oral, injectable, transdermal, inhalation, and implantable devices, catering to a broad end-use base in hospitals, clinics, and home care settings. The necessity of sophisticated drug delivery mechanisms is underscored by the ongoing demand for more precise, efficient, and patient-friendly treatment solutions, fueled by advancements in biotechnology and nanotechnology.

Key growth factors influencing this market include increasing prevalence of chronic diseases, growing demand for biologics and biosimilars, and technological innovations in delivery techniques. Additionally, the rise in personalized medicine and biologic therapies presents significant opportunities for novel delivery systems that improve targeted action and bioavailability. For instance, innovations such as smart drug delivery platforms and microparticle technologies are potential areas with high growth prospects. Businesses looking to capitalize on these opportunities should invest in R&D for cutting-edge systems like biodegradable polymers and nanocarriers. However, the market faces challenges from regulatory complexities, high developmental costs, and limitations in biotechnology knowledge, which can impede the rate of innovation and adoption.

Limitations in drug stability and patient adherence also pose hurdles that need addressing. Future innovation should focus on overcoming these barriers by enhancing materials science and engineering developments to create more adaptive and responsive delivery systems. Exploring the synergistic use of digital health technologies can further refine monitoring and management, enhancing the drug delivery landscape. Overall, the drug delivery systems market is both dynamic and challenging, requiring strategic investments in technology and regulatory navigation to seize emerging opportunities and drive sustained market growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Delivery Systems Market

The Drug Delivery Systems Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing prevalence of chronic & infectious diseases across the globe
  • Rising investment government support for healthcare infrastructure
  • Upsurge in the demand for personalized medicine
• Market Restraints
  • High cost associated with development of drug delivery systems
• Market Opportunities
  • Technological advancements in the production of drug delivery systems
  • Growing adoption of nanotechnology for efficient targeted drug delivery systems
• Market Challenges
  • Regulatory hurdles and time-consuming approval processes

Porter's Five Forces: A Strategic Tool for Navigating the Drug Delivery Systems Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Delivery Systems Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Delivery Systems Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Delivery Systems Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Delivery Systems Market

A detailed market share analysis in the Drug Delivery Systems Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Delivery Systems Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Delivery Systems Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Delivery Systems Market

A strategic analysis of the Drug Delivery Systems Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Delivery Systems Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AptarGroup, Inc., AstraZeneca Plc, Boston Scientific Corporation, Cospheric LLC, DelSiTech Ltd., Enable Injections, Inc., F. Hoffmann-La Roche Ltd., Insulet Corporation, Johnson & Johnson Services, Inc., Lonza Group Ltd., Merck KGaA, Merit Medical Systems, Inc., Novartis AG, Pacira BioSciences, Inc., Pfizer Inc., Polysciences Inc., Sanofi S.A., SHL Medical, Societal CDMO by CoreRx, Inc., Terumo Corporation, Thermo Fisher Scientific Inc., and West Pharmaceutical Services, Inc..

Market Segmentation & Coverage

This research report categorizes the Drug Delivery Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Delivery Type, market is studied across Inhalation Drug Delivery, Injection-Based Delivery, Nasal Drug Delivery, Ocular Drug Delivery, Oral Drug Delivery, Topical Drug Delivery, and Transdermal Drug Delivery.
• Based on Formulation, market is studied across Gas, Liquid, Semisolid, and Solid.
• Based on Drug Release Mechanism, market is studied across Controlled Release, Immediate Release, Sustained Release, and Targeted Release.
• Based on Application, market is studied across Cardiovascular Diseases, Central Nervous System Disorders, Diabetes, Infectious Diseases, Oncology, and Respiratory Diseases.
• Based on End-User, market is studied across Diagnostic Centers, Home Care Settings, and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of chronic & infectious diseases across the globe
    • 5.1.1.2. Rising investment government support for healthcare infrastructure
    • 5.1.1.3. Upsurge in the demand for personalized medicine
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with development of drug delivery systems
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in the production of drug delivery systems
    • 5.1.3.2. Growing adoption of nanotechnology for efficient targeted drug delivery systems
  • 5.1.4. Challenges
    • 5.1.4.1. Regulatory hurdles and time-consuming approval processes
• 5.2. Market Segmentation Analysis
  • 5.2.1. Delivery Type: Growing adoption transdermal drug delivery to ensure prolonged and controlled drug release
  • 5.2.2. Application: Growing prevalence of diabetes globally push need for continuous drug delivery system
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Drug Delivery Systems Market, by Delivery Type

• 6.1. Introduction
• 6.2. Inhalation Drug Delivery
• 6.3. Injection-Based Delivery
• 6.4. Nasal Drug Delivery
• 6.5. Ocular Drug Delivery
• 6.6. Oral Drug Delivery
• 6.7. Topical Drug Delivery
• 6.8. Transdermal Drug Delivery

7. Drug Delivery Systems Market, by Formulation

• 7.1. Introduction
• 7.2. Gas
• 7.3. Liquid
• 7.4. Semisolid
• 7.5. Solid

8. Drug Delivery Systems Market, by Drug Release Mechanism

• 8.1. Introduction
• 8.2. Controlled Release
• 8.3. Immediate Release
• 8.4. Sustained Release
• 8.5. Targeted Release

9. Drug Delivery Systems Market, by Application

• 9.1. Introduction
• 9.2. Cardiovascular Diseases
• 9.3. Central Nervous System Disorders
• 9.4. Diabetes
• 9.5. Infectious Diseases
• 9.6. Oncology
• 9.7. Respiratory Diseases

10. Drug Delivery Systems Market, by End-User

• 10.1. Introduction
• 10.2. Diagnostic Centers
• 10.3. Home Care Settings
• 10.4. Hospitals & Clinics

11. Americas Drug Delivery Systems Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Drug Delivery Systems Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Drug Delivery Systems Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Schott Pharma and Koru Medical Systems Partner to Innovate Drug Delivery for Improved Patient Care
  • 14.3.2. Difgen Boosts Production and Quality with Acquisition of FDA-Registered Facility
  • 14.3.3. Sharps Technology Launches New Drug Delivery Systems to Enhance Patient Safety and Reduce Administration Risks
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. AptarGroup, Inc.
• 3. AstraZeneca Plc
• 4. Boston Scientific Corporation
• 5. Cospheric LLC
• 6. DelSiTech Ltd.
• 7. Enable Injections, Inc.
• 8. F. Hoffmann-La Roche Ltd.
• 9. Insulet Corporation
• 10. Johnson & Johnson Services, Inc.
• 11. Lonza Group Ltd.
• 12. Merck KGaA
• 13. Merit Medical Systems, Inc.
• 14. Novartis AG
• 15. Pacira BioSciences, Inc.
• 16. Pfizer Inc.
• 17. Polysciences Inc.
• 18. Sanofi S.A.
• 19. SHL Medical
• 20. Societal CDMO by CoreRx, Inc.
• 21. Terumo Corporation
• 22. Thermo Fisher Scientific Inc.
• 23. West Pharmaceutical Services, Inc.